Skip to content

XIENCE XPEDITION 1074250-33Recalls & reported problems

Abbott Vascular Inc. · XIENCE Xpedition LL Everolimus Eluting Coronary Stent System 2.50 mm x 33 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE XPEDITION (41)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648162176), received between Jul 23, 2019 and Jul 23, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Dislodged or Dislocated1

Patient problems

  • No Patient Involvement1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 23, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated

    IT WAS REPORTED THAT DURING PREPARATION OF THE XIENCE STENT DELIVERY CATHETER (SDS) WHEN THE PROTECTIVE SHEATH WAS REMOVED, THE STENT CAME OFF. THERE WAS NO OTHER ISSUE. THERE WAS NO RESISTANCE DURING REMOVAL OF THE PROTECTIVE SHEATH. THE DEVICE WAS DISCARDED. A NEW SDS WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO PATIENT INVOLVEMENT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Patient Involvement

    MAUDE report 8816843 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page